CYTK - Company ID 0001061983
CYTOKINETICS INC (CYTK) reported net income of -$784.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$784.96M | -33.2% |
| FY 2024 | -$589.53M | -12.0% |
| FY 2023 | -$526.24M | -35.3% |
| FY 2022 | -$388.95M | -80.6% |
| FY 2021 | -$215.31M | -69.2% |
| FY 2020 | -$127.29M | -4.6% |
| FY 2019 | -$121.69M | -14.5% |
| FY 2018 | -$106.29M | +16.8% |
| FY 2017 |
CYTOKINETICS INC (CYTK) reported net income of -$784.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CYTOKINETICS INC's net income declined from -$47.86M to -$784.96M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$127.79M |
| -876.7% |
| FY 2016 | $16.45M | +143.9% |
| FY 2015 | -$37.50M | -156.0% |
| FY 2014 | -$14.65M | +56.6% |
| FY 2013 | -$33.72M | +16.5% |
| FY 2012 | -$40.37M | +15.6% |
| FY 2011 | -$47.86M | - |